Meeder Asset Management Inc Lumos Pharma, Inc. Transaction History

Meeder Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$9.75 - $13.44 $1,160 - $1,599	-119 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$11.58 - $31.11 $1,378 - $3,702	119 New	119 $1,000
Q4 2020 Feb 09, 2021	SELL	$13.61 - $35.91 $1,619 - $4,273	-119 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$13.25 - $16.5 $1,603 - $1,996	-121 Reduced 50.42%	119 $2,000
Q1 2020 May 15, 2020	BUY	$0.89 - $8.85 $213 - $2,124	240 New	240 $2,000

2.2M

Ticker LUMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,396,070
Market Cap $36.4M
Description
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.